If a patient received dexamethasone 4 mg at 8 am and insulin glargine (Lantus) 13 units at 2 pm today, and will not receive dexamethasone tomorrow, what should the insulin glargine dose be for the next day?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Reduce Lantus to approximately 10 units tomorrow

When dexamethasone is discontinued, the Lantus dose should be reduced by approximately 20-30% from the current dose to prevent hypoglycemia, bringing the dose from 13 units to approximately 9-10 units.

Rationale for Dose Reduction

Dexamethasone causes significant hyperglycemia that peaks 4-8 hours after administration and can persist for up to 24 hours 1. When a single 4 mg dose of dexamethasone is given in the morning (as in this case at 8 am), it creates disproportionate daytime hyperglycemia that typically resolves overnight 2. Once dexamethasone is stopped, the insulin requirements will drop substantially, creating a significant hypoglycemia risk if the full dose is continued 2.

The 2025 ADA Standards specifically note that for steroid-induced hyperglycemia, "Consider dosing NPH in the morning for steroid-induced hyperglycemia" 3. However, since this patient is already on Lantus (a long-acting basal insulin), the key principle is that insulin requirements can "decline rapidly after dexamethasone is stopped and insulin doses should be adjusted accordingly" 4.

Specific Dosing Algorithm

For this patient receiving 13 units of Lantus at 2 pm:

  • Tomorrow (day without dexamethasone): Reduce to 10 units (approximately 20-25% reduction)
  • Monitor closely: Check fasting and pre-meal glucose levels
  • Further titration: If hypoglycemia occurs (glucose <70 mg/dL), reduce by an additional 10-20% 3
  • If hyperglycemia persists: May need to increase back gradually by 2 units every 3 days 3

Critical Monitoring Points

The most important consideration is preventing hypoglycemia when the steroid effect wears off. The 2012 Endocrine Society guidelines emphasize that when evaluating home insulin regimens at hospitalization, dose reductions are often necessary, particularly noting that "the majority of hypoglycemic events occurred in patients treated with insulin before admission who were continued on the same insulin dose" 5.

For patients on glucocorticoids, guidelines recommend that "insulin requirements can decline rapidly after dexamethasone is stopped" 4, and the Diabetes UK guidance specifically states insulin doses should be adjusted accordingly when dexamethasone is discontinued 4.

Alternative Consideration

If this patient has underlying diabetes requiring basal insulin (not just steroid-induced hyperglycemia), the dose reduction is still warranted but may need less aggressive reduction. The FDA label for Lantus notes that dose adjustments should be made based on clinical response, and for hypoglycemia risk, doses should be lowered by 10-20% 6.

Monitor glucose levels closely over the next 24-48 hours, as the full effect of dexamethasone withdrawal will become apparent during this time 1. Be prepared to adjust further based on glucose readings, with particular attention to overnight and fasting values.

References

Research

Effect of dexamethasone on oral glucose tolerance in healthy adults.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2010

Guideline

management of diabetes and hyperglycaemia in the hospital.

The Lancet Diabetes and Endocrinology, 2021

Related Questions

In a 67-year-old female weighing 75 kg who received dexamethasone 10 mg 48 hours ago, has poor oral intake, and was given insulin glargine (Lantus) 36 units at 1500 h with a current insulin‑to‑carbohydrate ratio of 1 unit per 7 g carbohydrate and an insulin sensitivity factor of 1 unit per 25 mg/dL, what should the basal insulin dose, insulin sensitivity factor, and insulin‑to‑carbohydrate ratio be adjusted to?
In a 43‑year‑old woman (56 kg, normal renal function) who stopped dexamethasone after being on insulin glargine (Lantus) 24 U at 4 pm, should the initial basal dose be 12 U or 14 U?
What insulin glargine (Lantus) basal dose and fixed rapid‑acting insulin (insulin lispro) prandial doses should be used for each day of a dexamethasone taper from 4 mg to discontinuation?
For a 43-year-old female weighing 56 kg with normal renal function who received dexamethasone 4 mg yesterday and has glucose readings of 296, 396, 304, 373, and 251 mg/dL, currently using an insulin‑sensitivity factor of 25 mg/dL per unit, an insulin‑to‑carbohydrate ratio of 10 g per unit, and basal insulin (insulin glargine, Lantus) 24 U at 4 pm, what should the insulin‑sensitivity factor, insulin‑to‑carbohydrate ratio, and basal insulin dose be now that dexamethasone will be discontinued today?
Should I decrease my insulin glargine (Lantus) dose, currently 22 units, given a blood glucose of 219 mg/dL at 2 am and 152 mg/dL at 7 am?
What is the likely diagnosis for cervical spine pain triggered by car bumps and rapid turns, and how should it be evaluated and managed?
What is the likely diagnosis and recommended management for a painless, firm, mobile lump behind the ear?
Which of the following is not a complication of arterial hypertension: left ventricular hypertrophy, microalbuminuria, advanced retinopathy, renal insufficiency, or objective signs of arterial vascular disease?
What is the appropriate treatment for a 1‑year‑old boy presenting with ear canal drainage and swelling?
For a 69‑year‑old patient with bipolar disorder who is taking caplyta (lumateperone) 10.5 mg daily, which seems like a low dose, is it appropriate to start ketamine therapy for residual depression?
What are the common symptoms of gastric cancer?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.